Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

National Drug Code

Is NDC 0186-0777-08 recalled?

Brilinta

Yes — this exact package was recalled

1 FDA recall names the code 0186-0777-08 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.

Active ingredient
Ticagrelor
Strength
TICAGRELOR 90 mg/1
Form
Tablet · Oral
Labeler
AstraZeneca Pharmaceuticals LP
Type
Human Prescription Drug
Product code
0186-0777

Recalls naming this package

Class I ยท High risk

BRILINTA (ticagrelor)

Presence of Foriegn Tablets/Capsules: customer complaint that an 8-count professional sample bottle labeled as BRILINTA 90 mg tablets contained 5 ZURAMPIC 200 mg tablets, in addition to the expected 8 BRILINTA tablets.

Terminated Particulate / foreign matter AstraZeneca Pharmaceuticals, LP NDC 0186-0777-08 D-0958-2017

Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.

Other recalled products from this labeler